LIMONTA, PATRIZIA
 Distribuzione geografica
Continente #
EU - Europa 16.924
AS - Asia 10.119
NA - Nord America 9.438
SA - Sud America 1.060
AF - Africa 273
OC - Oceania 73
Continente sconosciuto - Info sul continente non disponibili 5
Totale 37.892
Nazione #
US - Stati Uniti d'America 8.967
IT - Italia 7.524
CN - Cina 3.556
GB - Regno Unito 2.948
SG - Singapore 2.512
DE - Germania 1.908
FR - Francia 867
HK - Hong Kong 842
RU - Federazione Russa 772
SE - Svezia 751
BR - Brasile 712
VN - Vietnam 546
NL - Olanda 488
IN - India 426
BD - Bangladesh 418
TR - Turchia 412
KR - Corea 316
FI - Finlandia 266
IE - Irlanda 260
JP - Giappone 233
CA - Canada 205
MX - Messico 190
ID - Indonesia 173
DK - Danimarca 172
ES - Italia 152
UA - Ucraina 137
TW - Taiwan 127
PL - Polonia 102
EU - Europa 97
AR - Argentina 90
MY - Malesia 87
AT - Austria 86
GR - Grecia 86
PH - Filippine 68
BE - Belgio 67
CO - Colombia 66
PE - Perù 64
RO - Romania 60
CH - Svizzera 59
CI - Costa d'Avorio 59
IL - Israele 59
AU - Australia 53
CL - Cile 49
IQ - Iraq 48
ZA - Sudafrica 44
EG - Egitto 43
IR - Iran 42
PT - Portogallo 41
PK - Pakistan 40
TH - Thailandia 38
EC - Ecuador 31
HU - Ungheria 26
SA - Arabia Saudita 26
CU - Cuba 25
VE - Venezuela 25
AL - Albania 24
CY - Cipro 22
CZ - Repubblica Ceca 21
NO - Norvegia 21
NG - Nigeria 20
NZ - Nuova Zelanda 20
MA - Marocco 18
AE - Emirati Arabi Uniti 16
UZ - Uzbekistan 16
RS - Serbia 15
TN - Tunisia 14
DZ - Algeria 13
LB - Libano 13
SK - Slovacchia (Repubblica Slovacca) 13
NP - Nepal 12
CR - Costa Rica 11
KE - Kenya 11
PY - Paraguay 11
BG - Bulgaria 10
ET - Etiopia 10
HR - Croazia 8
OM - Oman 8
SC - Seychelles 8
KW - Kuwait 7
LT - Lituania 7
SY - Repubblica araba siriana 7
JO - Giordania 6
ME - Montenegro 6
MO - Macao, regione amministrativa speciale della Cina 6
NI - Nicaragua 6
PA - Panama 6
UY - Uruguay 6
EE - Estonia 5
JM - Giamaica 5
KG - Kirghizistan 5
KZ - Kazakistan 5
SI - Slovenia 5
TT - Trinidad e Tobago 5
GH - Ghana 4
HN - Honduras 4
LK - Sri Lanka 4
LV - Lettonia 4
PR - Porto Rico 4
AO - Angola 3
AZ - Azerbaigian 3
Totale 37.909
Città #
Southend 2.593
Milan 1.508
Singapore 1.373
Ashburn 787
Hong Kong 724
Hanover 701
Rome 633
Seattle 516
Chandler 509
Dallas 489
San Jose 479
Beijing 468
Fairfield 466
Frankfurt am Main 334
Council Bluffs 333
Wilmington 333
Princeton 290
Dublin 253
Houston 231
Woodbridge 223
Los Angeles 222
Ann Arbor 220
Shanghai 211
Santa Clara 208
Guangzhou 190
Nanjing 185
Redwood City 182
Redmond 165
Ho Chi Minh City 164
Florence 150
Bari 148
Cambridge 141
Helsinki 141
Munich 140
New York 140
Naples 139
Hanoi 137
Turin 133
Mountain View 127
Dearborn 122
Lauterbourg 122
Palermo 118
Moscow 113
Bengaluru 110
Des Moines 106
Buffalo 101
Jakarta 101
Jinan 98
Shenyang 94
Hefei 93
Tokyo 93
Boardman 92
Grafing 89
São Paulo 89
Toronto 83
Sakarya 82
Bologna 80
Wuhan 76
Taipei 73
Hangzhou 69
The Dalles 66
Zhengzhou 66
Seoul 64
Padova 63
Brescia 61
Catania 60
Verona 60
Abidjan 59
Lima 59
Changsha 58
Tianjin 58
Columbus 57
London 57
Phoenix 57
Messina 52
Istanbul 51
Genoa 50
Vienna 49
Chengdu 47
Perugia 46
Athens 44
Jacksonville 43
Nanchang 43
Shenzhen 43
Warsaw 42
Kuala Lumpur 41
Mannheim 41
Berlin 40
Bogotá 40
Fuzhou 40
San Diego 38
Brussels 37
Madrid 36
Atlanta 34
Cangzhou 34
Mexico City 33
Washington 33
Rio de Janeiro 30
Amsterdam 29
Andover 29
Totale 20.280
Nome #
Becker : Il mondo della cellula 5.560
GnRH and GnRH receptors in the pathophysiology of the human female reproductive system 2.085
The emerging role of paraptosis in tumor cell biology: Perspectives for cancer prevention and therapy with natural compounds 1.185
Anticancer properties of tocotrienols : a review of cellular mechanisms and molecular targets 856
HEBE project: Healthy aging versus inflamm-aging: The role of physical exercise in modulating the biomarkers of age-associated and environmentally determined chronic diseases, study protocol 671
Dual role of autophagy on docetaxel-sensitivity in prostate cancer cells 562
δ‐Tocotrienol induces apoptosis, involving endoplasmic reticulum stress and autophagy, and paraptosis in prostate cancer cells 552
Molecular mechanisms and genetic alterations in prostate cancer: From diagnosis to targeted therapy 536
Cellular and molecular biology of cancer stem cells in melanoma : possible therapeutic implications 513
Heterologous and cross-species tropism of cancer-derived extracellular vesicles 464
The luteinizing hormone-releasing hormone receptor in human prostate cancer cells: messenger ribonucleic acid expression, molecular size, and signal transduction pathway 437
The multifaceted roles of mitochondria at the crossroads of cell life and death in cancer 430
Beneficial effects of δ-tocotrienol against oxidative stress in osteoblastic cells: studies on the mechanisms of action 421
Ca2+ overload- and ROS-associated mitochondrial dysfunction contributes to δ-tocotrienol-mediated paraptosis in melanoma cells 418
miR-205 exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase C epsilon 412
Dual targeting of tumor and endothelial cells by Gonadotropin-Releasing Hormone agonists to reduce melanoma angiogenesis 397
Unraveling the molecular mechanisms and the potential chemopreventive/therapeutic properties of natural compounds in melanoma 396
Type I Gonadotropin-Releasing Hormone Receptor Mediates the Antiproliferative Effects of GnRH-II on Prostate Cancer cells 375
Segnalazione cellulare e trasduzione del segnale : comunicazione fra le cellule 359
Role of Endoplasmic Reticulum Stress in the Anticancer Activity of Natural Compounds 357
Evaluation of a stable Gonadotropin-Releasing Hormone analog in mice for the treatment of endocrine disorders and prostate cancer 351
Patologie prostatiche e LUTS 339
Epithelial-To-Mesenchymal Transition Markers and CD44 Isoforms Are Differently Expressed in 2D and 3D Cell Cultures of Prostate Cancer Cells 317
Growth-inhibitory activity of melatonin on human androgen-independent DU 145 prostate cancer cells 312
Clusterin isoforms differentially affect growth and motility of prostate cells : possible implications in prostate tumorigenesis 295
Il sistema di endomembrane e i perossisomi 293
Gonadotropin-releasing hormone receptors in prostate cancer : molecular aspects and biological functions 275
Unraveling the Peculiar Features of Mitochondrial Metabolism and Dynamics in Prostate Cancer 274
Cancer Stem Cells—Key Players in Tumor Relapse 273
Activation of the orphan nuclear receptor RORα induces growth arrest in androgen-independent DU 145 prostate cancer cells 271
Biologia Cellulare 265
Luteinizing hormone-releasing hormone agonists interfere with the mitogenic activity of the insulin-like growth factor system in androgen-independent prostate cancer cells 263
Gonadotropin-releasing hormone agonists reduce the migratory and the invasive behavior of androgen-independent prostate cancer cells by interfering with the activity of IGF-I 262
Natural Compounds in Prostate Cancer Prevention and Treatment: Mechanisms of Action and Molecular Targets 262
Mitochondrial functional and structural impairment is involved in the antitumor activity of δ-tocotrienol in prostate cancer cells 260
Insulin-like growth factor-I promotes migration in human androgen-independent prostate cancer cells via the alpha v beta 3 integrin and PI3-K/Akt signaling 259
Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop 251
Activation of the orphan nuclear receptor RORalpha counteracts the proliferative effect of fatty acids on prostate cancer cells : Crucial role of 5-lipoxygenase 248
New insights in melanoma biology : running fast towards precision medicine 246
Estrogen receptor β in melanoma : From molecular insights to potential clinical utility 242
Gonadotropin-Releasing Hormone Agonists Sensitize, and Resensitize, Prostate Cancer Cells to Docetaxel in a p53-Dependent Manner 240
Three-Dimensional Cell Cultures as an In Vitro Tool for Prostate Cancer Modeling and Drug Discovery 239
Adipocyte-Derived Extracellular Vesicles Promote Prostate Cancer Cell Aggressiveness by Enabling Multiple Phenotypic and Metabolic Changes 238
Castration Resistant Prostate Cancer : from Emerging Molecular Pathways to Targeted Therapeutic Approaches 234
In vitro 3D cultures to model the tumor microenvironment 229
Targeting melanoma stem cells with the Vitamin E derivative δ-tocotrienol 225
Vitamin E δ-tocotrienol triggers endoplasmic reticulum stress-mediated apoptosis in human melanoma cells 221
Inhibitory activity of luteinizing hormone-releasing hormone on tumor growth and progression 217
Ageing of the neuroendocrine system in the brain of male rats: receptor mechanisms and steroid metabolism 216
Estrogen receptor β agonists differentially affect the growth of human melanoma cell lines 212
Locally expressed LHRH receptors mediate the oncostatic and antimetastatic activity of LHRH agonists on melanoma cells 209
FROM EMERGING BIOLOGICAL INSIGHTS TO NOVEL TREATMENT STRATEGIES IN PROSTATE CANCER 208
Segnalazione cellulare e trasduzione del segnale: comunicazione fra le cellule 206
GnRH Receptors in Cancer: From Cell Biology to Novel Targeted Therapeutic Strategies 206
δ‐Tocotrienol sensitizes and re‐sensitizes ovarian cancer cells to cisplatin via induction of G1 phase cell cycle arrest and ROS/MAPK‐mediated apoptosis 206
Differentiation States of Phenotypic Transition of Melanoma Cells Are Revealed by 3D Cell Cultures 205
Dissecting the Hormonal Signaling Landscape in Castration-Resistant Prostate Cancer 201
Aging and the hypothalamo-pituitary-testicular axis in the rat 198
Novel insights into GnRH receptor activity : role in the control of human glioblastoma cell proliferation 193
GnRH in the Human Female Reproductive Axis 190
Binding characteristics of hypothalamic mu opioid receptors throughout the estrous cycle in the rat 188
Endocrinology of aging 187
Molecular mechanisms of the antimetastatic activity of nuclear clusterin in prostate cancer cells 186
Semi-preparative HPLC purification of δ-tocotrienol (δ-T3) from Elaeis guineensis Jacq. and Bixa orellana L. and evaluation of its in vitro anticancer activity in human A375 melanoma cells 184
Is the 5 alpha-reductase of the hypothalamus and of the anterior pituitary neurally regulated? Effects of hypothalamic deafferentations and of centrally acting drugs 182
Melanoma Stem Cells Educate Neutrophils to Support Cancer Progression 181
Effect of oestrus cyclicity on the number of brain opioid mu receptors in the rat 181
Androgen-dependent prostatic tumors: biosynthesis and possible actions of LHRH 179
AKR1C3 inhibition therapy in castration-resistant prostate cancer and breast cancer: lessons from responses to SN33638 179
Characterization of a soluble LHRH-degrading activity in the rat ventral prostate 178
Effects of aging on pituitary and testicular luteinizing hormone-releasing hormone receptors in the rat 176
Gonadotropin-releasing hormone agonists suppress melanoma cell motility and invasiveness throught the inhibition of a3 integrin and MMP-2 expression and activity 175
Antiproliferative action of melatonin on human prostate cancer LNCaP cells 170
Role of growth factors, steroid and peptide hormones in the regulation of human prostatic tumor growth 170
Dual role of autophagy on chemoresistance in prostate cancer cells 170
Tocotrienols and Cancer: From the State of the Art to Promising Novel Patents 168
Effect of aging on opioid and LHRH receptors in the brain, pituitary, and testis of the male rat 167
Hypothalamic ß-endorphin and brain mu opiate receptor concentrations in male rat after restraint stress 165
Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP 165
Endocrine responses to naloxone in young and old male rats. 165
Gonadotropin-Releasing Hormone (GnRH) receptors in tumors : a new rationale for the therapeutical application of GnRH analogs in cancer patients? 164
Decrease of mu opioid receptors in the brain and in the hypothalamus of the aged male rat 163
PGC1-α-driven mitochondrial biogenesis contributes to a cancer stem cell phenotype in melanoma 154
Binding characteristics of delta opioid receptors in different regions of the brain of young and old male rats as studied with the highly selective ligand [D-Pen2-D-Pen5] enkephalin 154
Testosterone and postnatal ontogenesis of hypothalamic mu ([3H]dihydromorphine) opioid receptors in the rat 154
Molecular Mechanisms of Cancer Drug Resistance: Emerging Biomarkers and Promising Targets to Overcome Tumor Progression 152
Gonadal steroid modulation of brain opioid systems 151
Role of serotoninergic neurones in the control of gonadotrophin and prolactin secretion in the rat 150
Effect of castration, hypothalamic deafferentation and treatment with neuroactive drugs on testosterone 5alpha-reductase activity in the hypothalamus and anterior pituitary 150
Comments on inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II, Jungwirth et al., Eur J Cancer 1997, 33(7), 1141-1148 149
Targeting Hormonal Signaling Pathways in Castration Resistant Prostate Cancer 149
Epithelial-to-mesenchymal transition markers are differently expressed in 2D and 3D cell cultures of prostate cancer cells 149
Oncostatic activity of a thiazolidinedione derivative on human androgen-dependent prostate cancer cells 146
Orientation-disturbing magnetic treatment affects the pigeon opioid system 146
Growth of the androgen-dependent tumor of the prostate: role of androgens and of locally expressed growth modulatory factors 146
Modulation by sex steroids of brain opioid receptors: implications for the control of gonadotropins and prolactin secretion 145
Growth factors in steroid-responsive prostatic tumor cells 145
Mitochondria as metabolic markers of melanoma stem cells and targets of delta-tocotrienol 144
Adipocytes reprogram prostate cancer stem cell machinery 143
Biologia cellulare 143
Totale 33.350
Categoria #
all - tutte 92.189
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.189


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021661 0 0 0 0 0 0 0 0 0 0 426 235
2021/20223.575 217 177 209 294 396 222 249 285 514 289 350 373
2022/20234.026 307 223 245 676 442 538 168 413 376 136 285 217
2023/20244.037 179 231 321 801 645 217 209 288 205 221 351 369
2024/20256.415 253 367 313 1.147 679 427 281 600 435 504 387 1.022
2025/20269.364 946 629 1.160 775 833 570 1.259 517 992 688 995 0
Totale 39.204